CWG
GILD icon

Cornerstone Wealth Group’s Gilead Sciences GILD Stock Holding History

Cornerstone Wealth Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Buy
3,659
+345
+10% +$45.5K 0.03% 255
2026
Q1 		$442K Buy
3,314
+238
+8% +$33.3K 0.03% 248
2025
Q4 		$378K Buy
3,076
+185
+6% +$22.5K 0.03% 245
2025
Q3 		$321K Buy
2,891
+69
+2% +$7.84K 0.02% 257
2025
Q2 		$313K Buy
2,822
+472
+20% +$50.2K 0.02% 242
2025
Q1 		$263K Buy
2,350
+184
+8% +$19K 0.02% 243
2024
Q4 		$200K Buy
+2,166
New +$195K 0.02% 265
2024
Q1 		– Sell
-36,295
Closed -$2.94M – 249
2023
Q4 		$2.94M Sell
36,295
-33,254
-48% -$2.59M 0.42% 69
2023
Q3 		$5.21M Sell
69,549
-897
-1% -$69K 0.92% 28
2023
Q2 		$5.43M Buy
70,446
+646
+0.9% +$51.5K 0.98% 26
2023
Q1 		$5.79M Sell
69,800
-13,685
-16% -$1.13M 1.03% 23
2022
Q4 		$7.17M Sell
83,485
-464
-0.6% -$36.7K 1.36% 16
2022
Q3 		$5.18M Buy
+83,949
New +$5.29M 1.14% 24
2022
Q1 		– Sell
-48,352
Closed -$3.51M – 152
2021
Q4 		$3.51M Buy
48,352
+1,961
+4% +$135K 0.6% 63
2021
Q3 		$3.24M Buy
+46,391
New +$3.26M 0.57% 63
2020
Q3 		– Sell
-34,810
Closed -$2.68M – 138
2020
Q2 		$2.68M Buy
34,810
+1,056
+3% +$80.9K 0.67% 43
2020
Q1 		$2.52M Sell
33,754
-4,401
-12% -$304K 0.89% 35
2019
Q4 		$2.48M Sell
38,155
-1,939
-5% -$126K 0.67% 53
2019
Q3 		$2.54M Buy
40,094
+19,679
+96% +$1.29M 0.64% 49
2019
Q2 		$1.38M Buy
+20,415
New +$1.34M 0.37% 83

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Wealth Group's GILD Position: Q2 2026 in Review

Cornerstone Wealth Group increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $45.5K and bringing the position to 3,659 shares worth $462K. The position accounts for 0.03% of the portfolio, ranked #255.

Cornerstone Wealth Group first reported a position in GILD in Q2 2019 and has held it in 20 quarters since. The position peaked at $7.17M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cornerstone Wealth Group held 3,659 shares of Gilead Sciences worth $462K as of Q2 2026.
  • Cornerstone Wealth Group bought 345 Gilead Sciences shares in Q2 2026, an estimated $45.5K.
  • Gilead Sciences made up 0.03% of Cornerstone Wealth Group's portfolio in Q2 2026, its #255 holding.
  • Cornerstone Wealth Group first reported a position in Gilead Sciences in Q2 2019 and has held it in 20 quarters since.
  • Cornerstone Wealth Group's Gilead Sciences position peaked at $7.17M in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.